CINGULATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7887 USD | -4.40% |
|
-1.65% | -89.69% |
| 21/05 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 08/05 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- CING Stock
- News Cingulate Inc.
- Transcripts
